Suspense crime, Digital Desk : Reckitt Benckiser, the global consumer goods giant behind iconic brands like Dettol and Lysol, is reportedly in advanced discussions to sell a significant portion of its Indian home care business, including household names like Harpic, Mortein, and Finit.

The company is said to be in exclusive negotiations with Advent International, a major US-based private equity firm. This move signifies a crucial step in Reckitt’s long-term strategy to streamline its operations and concentrate on its more profitable health and hygiene divisions, which include powerhouse brands such as Dettol, Durex, and Strepsils.

If the deal proceeds, it would mark a major shift in ownership for some of India’s most recognized cleaning and pest control products. The potential sale is estimated to be valued between Rs 5,000 crore and Rs 6,000 crore (approximately $600 to $720 million).

This is not the first time Reckitt has attempted to offload these non-core assets. A similar effort to sell the portfolio in 2021 did not result in a final deal. Now, by entering into exclusive talks with Advent, Reckitt has signaled its serious intent to complete the transaction, moving past other potential suitors like CVC Capital Partners and Warburg Pincus who were previously in the running.

For Advent International, this acquisition would represent another significant investment in the Indian market, adding to its portfolio which includes major stakes in companies like Suven Pharmaceuticals. The outcome of these high-stakes negotiations will be closely watched, as it could reshape a segment of India’s massive consumer goods landscape.

Read More: Harpic and Mortein May Get New Owner as Parent Company Reckitt Focuses on Health Brands